首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 整形外科 > 全球植入式微電子醫療器材市場:產品、技術及機會
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

全球植入式微電子醫療器材市場:產品、技術及機會

Microelectronic Medical Implants: Products, Technologies & Opportunities

出版商 BCC Research
出版日期 2011年05月 商品編碼 196809
內容資訊 英文 158 Pages
價格
US $ 4850 PDF by E-mail ( Single User License)
US $ 5950 PDF by E-mail (Business Unit License)
US $ 8500 PDF by E-mail (Enterprise License)


全球植入式微電子醫療器材市場:產品、技術及機會 是由出版商BCC Research在2011年05月所出版的。 這份英文市場調查報告書包含158 Pages 價格從美金4850起跳。

簡介

全球植入式微電子醫療器材市場於2010年已達154億美金規模,預計本市場於2011年將可達163億,2016年達248億美金成長,2011∼2016年之CAGR為8.8%。其中,成長最快之區隔為神經刺激器,其次為植入式藥劑幫浦及植入式助聽器。

本報告為,以產品類別、用途別調查分析植入式微電子醫療器材市場,並匯整各別市場規模及其預測、普及率、銷售成長、市場佔有率、市場驅力、挑戰、地區市場分析、主要企業簡介等,以下列摘要形式闡述。

第1章 簡介

第2章 摘要

第3章 概要

  • 概要
    • 定義
    • 歷史
  • 技術
    • 微型化
    • 材質
    • 感測器
    • 電源
    • RF技術
  • 應用
    • 心血管疾病
    • 神經系統疾病
    • 骨損害
    • 糖尿病
    • 癌症
    • 聽覺障礙
    • 視覺障礙
  • 產品類型
    • 心臟植入物
    • 神經刺激器
    • 脊柱融合刺激器
    • 植入式藥劑幫浦
    • 植入式助聽器
    • 眼部植入物
    • 配件及耗材

第4章 法規及法令挑戰

  • 美國
  • EU
  • 日本

第5章 全球植入式微電子醫療器材市場

  • 摘要
  • 詳細市場變化、預測:2002∼2009年

第6章 產業結構、競合

  • 市場佔有率

供應商簡介

圖表

目錄

Abstract

REPORT HIGHLIGHTS

  • The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
  • The global market for microelectronic implants will experience an 8.9% compound annual growth rate (CAGR) over the forecast period, from a value of $15.1 billion in 2011 to $23.1 billion in 2016.
  • The fastest-growing segments of the market are neurostimulators, with a projected compound annual growth rate (CAGR) of 10.5%, implantable drug pumps (10.5%), and ear implants (18.2%). Meanwhile, sales of cardiac implants and accessories are projected to lag behind, with compound annual growth rate (CAGR) of 7.4% and 8.4%, respectively.

SUMMARY FIGURE
GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, BY APPLICATION, 2010-2016
($ BILLIONS)

Source: BCC Research

REPORT SCOPE

INTRODUCTION

MICROELECTRONIC MEDICAL IMPLANTS

The first and still best-known type of microelectronic medical implant (MMI) is the pacemaker, introduced over 45 years ago. Assisting people with weak or failing hearts to live longer, fuller lives has continued to be a major focus of medical implant R&D. The pacemaker has been followed by a variety of other implantable cardiac devices, including defibrillators, loop recorders, heart assists, and even heart replacements.

Neurostimulators - implantable devices that employ the same principles as pacemakers for the purposes of neural stimulation - have also been introduced. Neurostimulators were used initially for pain relief, but are now being used for other neurological indications ranging from the treatment of urge incontinence to preventing epileptic seizures.

Other therapeutic implantable devices have followed, including bone growth stimulators, drug infusion pumps, ear implants that provide a semblance of hearing for the deaf, and new middle ear implants. Eye implants that can restore limited vision to people with certain types of blindness were recently approved for use in some markets.

STUDY BACKGROUND

The microelectronic implant industry has come a long way since the first heart pacemakers appeared on the market in the 1970s. Some products such as neurostimulators have evolved directly from the pacemaker. Other devices, such implantable drug infusion pumps, would have been impossible without the development of increasingly sophisticated sensors-on-a-chip and the miniaturization of mechanical parts and circuitry.

Despite these advances, the product cycle in this industry lags considerably behind the available technology due to the lengthy nature of the clinical testing and approval process for new medical devices. As a result, new products often leapfrog their predecessors in terms of features and capabilities.

STUDY GOALS AND OBJECTIVES

Thus, this report is both a survey of products in the marketplace and a preview of things to come. The goal of the report is to examine market opportunities for the microelectronic medical implant industry and the technologies that make possible the more advanced products that are rapidly coming into being.

Specific objectives of the report include analyzing:

  • Major implant types and applications, both commercial and developmental.
  • Global market size and segmentation, including historical data on sales by application and implant type.
  • Market drivers and constraints.
  • Detailed market projections through 2016.
  • Industry structure, competition and market shares.
  • Factors that may influence the long-term market for microelectronic implants.

SCOPE OF THE STUDY

This report covers microelectronic devices designed to operate within the human body, including:

  • Pacemakers.
  • Implantable cardioverter defibrillators (ICDs).
  • Implantable loop recorders.
  • Ventricular assist blood pumps.
  • Artificial hearts.
  • Neurostimulator devices used to combat pain, or to treat epilepsy, Parkinson' s disease, and incontinence.
  • Spinal fusion stimulators.
  • Implanted drug infusion pumps.
  • Implanted monitoring devices.
  • Cochlear implants to treat the profoundly deaf.
  • Retinal implants being developed to treat the blind.

The scope of the report also includes implant-related accessories and supplies, such as batteries and leads. However, the report does not directly cover ancillary devices that function outside the body, such as external telemetry devices and power sources. These are covered in this report only to the extent that is necessary to maintain coherence.

The market projections also do not include the cost of surgical procedures used to insert the devices.

The report covers the entire global market for microelectronic implants. In some segments there is a greater focus on the U.S. market due to greater data availability, but in such cases the global implications of developments in the United States are also analyzed.

METHODOLOGY AND INFORMATION SOURCES

The findings and conclusions of this report are based on information gathered from manufacturers and distributors of microelectronic implants, hospitals, doctors, and other end users. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and online databases to produce the baseline market estimates contained in this report.

The base year for analysis and projection is 2010. In cases for which year-end data for 2010 are not available, figures were extrapolated from 2009 demand statistics and historical trends.

With 2010 as a baseline, market projections were developed for 2011 through 2016. These projections are based on a combination of a consensus among the primary contacts combined with our understanding of the key market drivers and their impact from a historical and an analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.

All dollar projections presented in this report are in 2010 constant dollars.

ANALYST CREDENTIALS

The author of this report is Andrew McWilliams. Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm 43rd Parallel LLC, is the author of several other BCC Research studies of the healthcare and related industries.

Table of Contents

Microelectronic Medical Implants: Products, Technologies & Opportunities

Chapter - 1: INTRODUCTION - Complimentary

  • MICROELECTRONIC MEDICAL IMPLANTS
  • STUDY BACKGROUND
  • STUDY GOALS AND OBJECTIVES
  • INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • RELATED BCC REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter - 2: SUMMARY

  • Table 0: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, BY APPLICATION, THROUGH 2016
  • Figure 0: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, BY APPLICATION, 2010-2016

Chapter - 3: OVERVIEW

  • GENERAL DESCRIPTION
  • TECHNOLOGIES
  • APPLICATIONS
  • PRODUCT TYPES

Chapter - 4: REGULATORY AND LEGISLATIVE ISSUES

  • UNITED STATES
  • EUROPEAN UNION
  • JAPAN

Chapter - 5: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS

  • SUMMARY
  • DETAILED MARKET ESTIMATES AND PROJECTIONS, 2002-2009
  • Table 12: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY TYPE OF IMPLANT, THROUGH 2016
  • Figure 13: TRENDS IN MICROELECTRONIC MEDICAL IMPLANT APPLICATION MARKET SHARES, 2010 AND 2016
  • Table L-13 :

Chapter - 6: INDUSTRY STRUCTURE AND COMPETITION

  • MARKET SHARES

Chapter - 7: VENDOR PROFILES

  • ABIOMED, INC.
  • ADVANCED BIONICS CORP.
  • ADVANCED NEUROMODULATION SYSTEMS DIVISION OF ST. JUDE MEDICAL
  • BIOMET, INC.
  • BIOPHAN TECHNOLOGIES, INC.
  • BIOTRONIK GMBH
  • CLEVELAND FES CENTER
  • COCHLEAR LIMITED
  • CYBERONICS, INC.
  • THE DOBELLE INSTITUTE
  • ENVOY MEDICAL
  • FINETECH MEDICAL LTD.
  • MED-EL
  • MEDTRONIC INC.
  • MICROMED TECHNOLOGY INC.
  • MIV THERAPEUTICS INC.
  • NEUROPACE, INC.
  • OTOLOGICS, LLC
  • RETINA IMPLANT AG
  • SOUNDTEC, INC.
  • ST. JUDE MEDICAL, INC.
  • SECOND SIGHT MEDICAL PRODUCTS, INC.
  • THORATEC CORPORATION
  • WILSON GREATBATCH TECHNOLOGIES, INC.
  • WORLDHEART CORPORATION

List of Tables

  • Summary Table: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, BY APPLICATION, THROUGH 2016
  • Table 1: HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS, AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2009
  • Table 2: HEART PACEMAKER MANUFACTURERS
  • Table 3: IMPLANTABLE DEFIBRILLATOR MANUFACTURERS
  • Table 4: CARDIAC RESYNCHRONIZATION DEVICE MANUFACTURERS
  • Table 5: IMPLANTABLE HEART ASSIST DEVICES
  • Table 6: CARDIAC ASSIST/REPLACEMENT DEVICE MANUFACTURERS
  • Table 7: SPINAL CORD STIMULATOR MANUFACTURERS
  • Table 8: SPINAL FUSION STIMULATOR MANUFACTURERS
  • Table 9: IMPLANTABLE DRUG PUMP MANUFACTURERS
  • Table 10: COCHLEAR IMPLANT MANUFACTURERS
  • Table 11: MIDDLE EAR IMPLANT MANUFACTURERS
  • Table 12: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY TYPE OF IMPLANT, THROUGH 2016
  • Table 13: GLOBAL MARKET FOR CARDIAC IMPLANTS, THROUGH 2016
  • Table 14: TRENDS IN GLOBAL PACEMAKER SALES, THROUGH 2016
  • Table 15: ICD INDICATIONS
  • Table 16: TRENDS IN GLOBAL ICD SALES, THROUGH 2016
  • Table 17: U.S. POPULATION AGED 55 AND OLDER, THROUGH 2016
  • Table 18: TRENDS IN GLOBAL ILR SALES, THROUGH 2016
  • Table 19: TRENDS IN GLOBAL SALES OF CARDIAC ASSIST AND REPLACEMENT DEVICES, THROUGH 2016
  • Table 20: GLOBAL MARKET FOR NEUROSTIMULATORS, THROUGH 2016
  • Table 21: GLOBAL MARKET FOR SPINAL NERVE STIMULATORS, THROUGH 2016
  • Table 22: GLOBAL MARKET FOR SPINAL NERVE STIMULATORS USED FOR CHRONIC PAIN MANAGEMENT, THROUGH 2016
  • Table 23: GLOBAL MARKET FOR SPINAL NERVE STIMULATORS USED FOR SPINAL CORD INJURY, THROUGH 2016
  • Table 24: TRENDS IN SALES OF SPINAL STIMULATORS FOR MANAGING URGE INCONTINENCE, THROUGH 2016
  • Table 25: TRENDS IN VNS STIMULATOR SALES, THROUGH 2016
  • Table 26: TRENDS IN DEEP BRAIN STIMULATOR SALES, THROUGH 2016
  • Table 27: TRENDS IN IMPLANTABLE SPINAL FUSION STIMULATOR SALES, THROUGH 2016
  • Table 28: IMPLANTABLE DRUG PUMP SALES, THROUGH 2016
  • Table 29: SALES OF HEARING IMPLANTS, THROUGH 2016
  • Table 30: COCHLEAR IMPLANT SALES, THROUGH 2016
  • Table 31: MIDDLE EAR IMPLANT SALES, THROUGH 2016
  • Table 32: MARKET FOR RETINAL IMPLANTS, THROUGH 2016
  • Table 33: SALES OF IMPLANTABLE LEADS AND ELECTRODES, THROUGH 2016

List of Figures

  • Summary Figure: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, BY APPLICATION, 2010-2016
  • Figure 1: TRENDS IN U.S. CANCER DEATHS, 1998-2010
  • Figure 2: U.S. PACEMAKER-RELATED PATENTS ISSUED THROUGH 3/1/2011
  • Figure 3: U.S. ICD-RELATED PATENTS ISSUED THROUGH 3/1/2011
  • Figure 4: U.S. CARDIAC RESYNCHRONIZATION DEVICE PATENTS ISSUED THROUGH 3/1/2011
  • Figure 5: U.S. CARDIAC ASSIST/REPLACEMENT DEVICE PATENT HOLDERS PATENTS AS OF 3/1/2011
  • Figure 6: GASTRIC ELECTRICAL STIMULATION TECHNOLOGY PATENTS
  • Figure 7: CORTICAL STIMULATION TECHNOLOGY PATENTS
  • Figure 8: DEEP BRAIN STIMULATION TECHNOLOGY PATENTS
  • Figure 9: U.S. COCHLEAR IMPLANT PATENT HOLDERS
  • Figure 10: U.S. MIDDLE EAR IMPLANT PATENT HOLDERS
  • Figure 11: U.S. RETINAL IMPLANT PATENT HOLDERS
  • Figure 12: TRENDS IN THE GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, 2010-2016
  • Figure 13: TRENDS IN MICROELECTRONIC MEDICAL IMPLANT APPLICATION MARKET SHARES, 2010 AND 2016
  • Figure 14: TRENDS IN CARDIOVASCULAR IMPLANT MARKET SHARES, 2010 AND 2016
  • Figure 15: IMPLANTED NEUROSTIMULATOR MARKET SHARES, 2010 AND 2016
  • Figure 16: SPINAL NERVE STIMULATOR CHRONIC PAIN MANAGEMENT MARKET PENETRATION, 2010
  • Figure 17: VNS EPILEPSY MARKET PENETRATION, 2010
  • Figure 18: DEEP BRAIN STIMULATION IMPLANT MARKET PENETRATION, 2010
  • Figure 19: GROWTH IN SALES OF IMPLANTABLE DRUG PUMPS VERSUS TRENDS IN MAJOR TARGET MARKETS, THROUGH 2008
  • Figure 20: COCHLEAR IMPLANT MARKET PENETRATION, 2010
  • Figure 21: CARDIAC PACEMAKER MARKET SHARES, 2010
  • Figure 22: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SHARES, 2010
  • Figure 23: IMPLANTABLE HEART ASSIST/REPLACEMENT DEVICE MARKET SHARES, 2010
  • Figure 24: SPINAL STIMULATOR MARKET SHARES, 2010
  • Figure 25: SPINAL FUSION STIMULATOR MARKET SHARES, 2010
  • Figure 26: IMPLANTABLE DRUG PUMP MARKET SHARES, 2010
  • Figure 27: COCHLEAR IMPLANT MARKET SHARES, 2010
Back to Top